Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/CO-CDPHE-2102544747/2021 was isolated from a human on December 29, 2021, in Colorado, USA. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV-19/USA/COCDPHE-2102544747/2021 is assigned lineage BA.2 (Pango v.3.1.20 2022-02-28), Omicron (BA.2-like (Scorpio) and GISAID clade GRA using Phylogenetic Assignment of Named Global Outbreak lineages (PANGO) tool. The complete genome of the clinical isolate of SARS-CoV-2, hCoV-19/USA/CO-CDPHE-2102544747/2021 has been sequenced (GISAID:EPI_ISL_8643930).

Heat inactivated viral culture fluids are sold as consumable testing materials. The suitability and performance characteristics should be determined by your laboratory for each intended usage. These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans.

For BSL-2 or BSL-3 compliant labs only / -20° C.
Product Insert.pdf

Material Safety Data Sheet.pdf